120 related articles for article (PubMed ID: 37929674)
1. Identification and validation of immune-related methylated genes as diagnostic and prognostic biomarkers of nasopharyngeal carcinoma.
Zou Z; Li R; Huang X; Chen M; Tan J; Wu M
Head Neck; 2024 Jan; 46(1):192-211. PubMed ID: 37929674
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
3. Identifying Key Genes for Nasopharyngeal Carcinoma by Prioritized Consensus Differentially Expressed Genes Caused by Aberrant Methylation.
Chen Y; Zhou C; Li H; Li H; Li Y
J Cancer; 2021; 12(3):874-884. PubMed ID: 33403044
[No Abstract] [Full Text] [Related]
4. DNA Methylation Biomarkers for Nasopharyngeal Carcinoma: Diagnostic and Prognostic Tools.
Jiang W; Cai R; Chen QQ
Asian Pac J Cancer Prev; 2015; 16(18):8059-65. PubMed ID: 26745039
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation-based diagnostic and prognostic biomarkers of nasopharyngeal carcinoma patients.
Wu ZH; Zhou T; Sun HY
Medicine (Baltimore); 2020 Jun; 99(24):e20682. PubMed ID: 32541515
[TBL] [Abstract][Full Text] [Related]
6. Differentially Infiltrated Identification of Novel Diagnostic Biomarkers Associated with Immune Infiltration in Nasopharyngeal Carcinoma.
Gao P; Lu W; Hu S; Zhao K
Dis Markers; 2022; 2022():3934704. PubMed ID: 36438903
[TBL] [Abstract][Full Text] [Related]
7. Detection and Analysis of RNAs Expression Profile for Methylated Candidate Tumor Suppressor Genes in Nasopharyngeal Carcinoma.
Zhao S; Zhang Y; Liang X; Li M; Peng F; Chen Z; Chen Y
Anticancer Agents Med Chem; 2019; 19(6):772-782. PubMed ID: 30714531
[TBL] [Abstract][Full Text] [Related]
8. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
9.
Lyu JY; Chen JY; Zhang XJ; Zhang MW; Yu GS; Zhang L; Wen Z
Dis Markers; 2020; 2020():7253531. PubMed ID: 32454907
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Therapeutic Gene Markers in Nasopharyngeal Carcinoma Based on Bioinformatics Analysis.
Xue K; Cao J; Wang Y; Zhao X; Yu D; Jin C; Xu C
Clin Transl Sci; 2020 Mar; 13(2):265-274. PubMed ID: 31863646
[TBL] [Abstract][Full Text] [Related]
11. Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis.
Pan X; Liu JH
Bioengineered; 2021 Dec; 12(1):3647-3661. PubMed ID: 34261404
[TBL] [Abstract][Full Text] [Related]
12. An immune-related prognostic model predicts neoplasm-immunity interactions for metastatic nasopharyngeal carcinoma.
Chen X; Ding Q; Lin T; Sun Y; Huang Z; Li Y; Hong W; Chen X; Wang D; Qiu S
Front Immunol; 2023; 14():1109503. PubMed ID: 37063853
[TBL] [Abstract][Full Text] [Related]
13. Identification of markers for predicting prognosis and endocrine metabolism in nasopharyngeal carcinoma by miRNA-mRNA network mining and machine learning.
Zhang X; Li X; Wang C; Wang S; Zhuang Y; Liu B; Lian X
Front Endocrinol (Lausanne); 2023; 14():1174911. PubMed ID: 37538797
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of DNA methylation in Epstein-Barr virus-associated nasopharyngeal carcinoma by bisulfite amplicon sequencing.
Zhao W; Mo Y; Wang S; Midorikawa K; Ma N; Hiraku Y; Oikawa S; Huang G; Zhang Z; Murata M; Takeuchi K
BMC Cancer; 2017 Jul; 17(1):489. PubMed ID: 28716111
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma.
Jiang W; Liu N; Chen XZ; Sun Y; Li B; Ren XY; Qin WF; Jiang N; Xu YF; Li YQ; Ren J; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Mai HQ; Zeng MS; Kang TB; Jia WH; Shao JY; Ma J
Mol Cancer Ther; 2015 Dec; 14(12):2864-73. PubMed ID: 26443805
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma.
Wong TS; Kwong DL; Sham JS; Tsao SW; Wei WI; Kwong YL; Yuen AP
Clin Cancer Res; 2003 Aug; 9(8):3042-6. PubMed ID: 12912954
[TBL] [Abstract][Full Text] [Related]
17. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
[No Abstract] [Full Text] [Related]
18. Comprehensive analysis of gene expression and DNA methylation for human nasopharyngeal carcinoma.
Li H; Wang FL; Shan LP; An J; Liu ML; Li W; Zhang JE; Wu PP
Eur Arch Otorhinolaryngol; 2019 Sep; 276(9):2565-2576. PubMed ID: 31240455
[TBL] [Abstract][Full Text] [Related]
19. Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma.
Dai W; Cheung AK; Ko JM; Cheng Y; Zheng H; Ngan RK; Ng WT; Lee AW; Yau CC; Lee VH; Lung ML
Cancer Med; 2015 Jul; 4(7):1079-90. PubMed ID: 25924914
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
